Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101
MINNEAPOLIS, Aug. 14, 2023 -- Panbela Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical... -Today at 08:15 am- MarketScreener